Hypothesis-based weight of evidence: A tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action—naphthalene as an example

References

• Abdo KM, Eustis SL, McDonald M, Jokinen MP, Adkins B, Haseman JK. (1992). Naphthalene: A respiratory tract toxicant and carcinogen for mice. Inhal Toxicol 4:393–409.
   Google Scholar
• Abdo KM, Grumbein S, Chou BJ, Herbert R. (2001). Toxicity and carcinogenicity study in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhal Toxicol 13:931–950.
   PubMed Web of Science ®Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR). (2005). Toxicological profile for naphthalene, 1-methylnaphthalene, and 2-methylnaphthalene. Atlanta: ATSDR, 347 pp, August.
   Google Scholar
• Bagchi D, Bagchi M, Balmoori J, Vuchetich PJ, Stohs SJ. (1998a). Induction of oxidative stress and DNA damage by chronic administration of naphthalene to rats. Res Commun Mol Pathol Pharmacol 101:249–257.
   PubMed Web of Science ®Google Scholar
• Bagchi M, Bagchi D, Balmoori J, Ye X, Stohs SJ. (1998b). Naphthalene-induced oxidative stress and DNA damage in cultured macrophage J774A.1 cells. Free Radic Biol Med 25:137–143.
   PubMed Web of Science ®Google Scholar
• Bagchi D, Balmoori J, Bagchi M, Ye X, Williams CB, Stohs SJ. (2000). Role of p53 tumor suppressor gene in the toxicity of TCDD, endrin, naphthalene, and chromium (VI) in liver and brain tissues of mice. Free Radic Biol Med 28:895–903.
   PubMed Web of Science ®Google Scholar
• Bagchi D, Balmoori J, Bagchi M, Ye X, Williams CB, Stohs SJ. (2002). Comparative effects of TCDD, endrin, naphthalene and chromium (VI) on oxidative stress and tissue damage in the liver and brain tissues of mice. Toxicology 175:73–82.
   PubMed Web of Science ®Google Scholar
• Baldwin RM, Jewell WT, Fanucci MV, Plopper C, Buckpitt A. (2004). Comparison of pulmonary/nasal CYP2F expression levels in rodents and rhesus macaque. J Pharmacol Exp Ther 309:127–136.
   PubMed Web of Science ®Google Scholar
• Baldwin, RM, Shultz MA, Buckpitt AR. (2005). Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 312:857–865.
   PubMed Web of Science ®Google Scholar
• Belous AR, Hachey DL, Dawling S, Roodi N, Parl FF. (2007). Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res 67:812–817.
   PubMed Web of Science ®Google Scholar
• Bogen KT. (2008). An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: The case of naphthalene-induced nasal tumors in rats. Risk Anal 28:1033–1051.
   PubMed Web of Science ®Google Scholar
• Bogen KT, Benson JM, Yost GS, Morris JB, Dahl AR, Clewell HJ, Krishnan K, Omiecinski CJ. (2008). Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regul. Toxicol. Pharmacol. 51(2 Suppl 1):27–36.
   Web of Science ®Google Scholar
• Boland B, Lin CY, Morin D, Miller L, Plopper C, Buckpitt A. (2004). Site-specific metabolism of naphthalene and 1-nitronaphthalene in dissected airways of rhesus macaques. J Pharmacol Exp Ther 310:546–554.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36:781–792.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Boffetta P, La Vecchia C. (2007). Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: A quantitative review to 2005. Ann Oncol 18:431–446.
   PubMed Web of Science ®Google Scholar
• Boysen G, Pachkowski BF, Nakamura J, Swenberg JA. (2009). The formation and biological significance of N7-guanine adducts. Mutat Res 678:76–94.
   PubMed Web of Science ®Google Scholar
• Brusick D. (2008). Critical assessment of the genetic toxicity of naphthalene. Regul Toxicol Pharmacol 51(2 Suppl 1):37–42.
   PubMed Web of Science ®Google Scholar
• Brusick D, Small MS, Cavalieri EL, Chakravarti D, Ding X, Longfellow DG, Nakamura J, Rogan EC, Swenberg JA. (2008). Possible genotoxic modes of action for naphthalene. Regul Toxicol Pharmacol 51(2 Suppl 1):43–50.
   Web of Science ®Google Scholar
• Buckpitt AR, Bahnson LS. (1986). Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41:331–341.
   Web of Science ®Google Scholar
• Buckpitt A, Buonarati M, Avey LB, Chang AM, Morin D, Plopper CG. (1992). Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. J Pharmacol Exp Ther 261:364–372.
   PubMed Web of Science ®Google Scholar
• Buckpitt A, Chang AM, Weir A, Van Winkle L, Duan X, Philpot R, Plopper C. (1995). Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol Pharmacol 47:74–81.
   PubMed Web of Science ®Google Scholar
• Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, West J, Fanucci M, Van Winkle L, Plopper C. (2002). Naphthalene-induced respiratory tract toxicity: Metabolic mechanisms of toxicity. Drug Metab Rev 34:791–820.
   PubMed Web of Science ®Google Scholar
• Chang JH, Kochansky CJ, Shou M. (2006). The role of P-glycoprotein in the bioactivation of raloxifene. Drug Metab Dispos 34:2073–2078.
   PubMed Web of Science ®Google Scholar
• Cho TM, Rose RL, Hodgson E. (2006). In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metab Dispos 34:176–183.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Meek ME, Klaunig JE, Patton DE, Fenner-Crisp PA. (2003). The human relevance of information on carcinogenic modes of action: Overview. Crit Rev Toxicol 33:581–589.
   PubMed Web of Science ®Google Scholar
• Cruzan G, Bus J, Gingell R, Carlson G. (2009). Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: An endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Regul Toxicol Pharmacol 55:205–218.
   PubMed Web of Science ®Google Scholar
• DeStefano-Shields C, Morin D, Buckpitt A. (2010). Formation of covalently bound protein adducts from the cytotoxicant naphthalene in nasal epithelium: Species comparisons. Environ Health Perspect 118:647–652.
   PubMed Web of Science ®Google Scholar
• Ding X, Kaminsky LS. (2003). Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149–173.
   PubMed Web of Science ®Google Scholar
• Eustis SL. (1989). The sequential development of cancer: A morphological perspective. Toxicol Lett 49:267–281.
   PubMed Web of Science ®Google Scholar
• Flowers-Geary L, Bleczinki W, Harvey RG, Penning TM. (1996). Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon ortho-quinones produced by dihydrodiol dehydrogenase. Chem Biol Interact 99:55–72.
   PubMed Web of Science ®Google Scholar
• Fukami T, Katoh M, Yamazaki H, Yokoi T, Nakajima M. (2008). Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: Naphthalene, styrene, and toluene. Chem Res Toxicol 21:720–725.
   PubMed Web of Science ®Google Scholar
• Genter MB, Marlowe J, Kerzee JK, Dragin N, Puga A, Dalton TP, Nebert DW. (2006). Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs. Biochem Biophys Res Commun 348:120–123.
   PubMed Web of Science ®Google Scholar
• Goodman JE, Prueitt RL, Dodge DG, Thakali S. (2009). Carcinogenicity assessment of water-soluble nickel compounds. Crit Rev Toxicol 39:365–417.
   PubMed Web of Science ®Google Scholar
• Green T, Lee R, Toghill A, Meadowcraft S, Lund V, Foster J. (2001). The toxicity of styrene to the nasal epithelium of mice and rats: Studies on the mode of action and relevance to humans. Chem Biol Interact 137:185–202.
   PubMed Web of Science ®Google Scholar
• Griego FY, Bogen KT, Price PS, Weed DL. (2008). Exposure, epidemiology and human cancer incidence of naphthalene. Regul Toxicol Pharmacol 51(2 Suppl 1):22–26.
   Web of Science ®Google Scholar
• Hill AB. (1965). The environment and disease: Association or causation? Proc R Soc Med 58:295–300.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Jajoo HK, Kim HY, Zhou L, Horton P, Harris CM, Harris TM. (1995). An efficient route to N6 deoxyadenosine adducts of diol epoxides of carcinogenic polycyclic aromatic hydrocarbons. Bioorg Med Chem 3:811–822.
   PubMed Web of Science ®Google Scholar
• Kim HY, Finneman JI, Harris CM, Harris TM. (2000). Studies of the mechanisms of adduction of 2'-deoxyadenosine with styrene oxide and polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem Res Toxicol 13:625–637.
   PubMed Web of Science ®Google Scholar
• Lanza DL, Code E, Crespi CL, Gonzalez FJ, Yost GS. (1999). Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 27:798–803.
   PubMed Web of Science ®Google Scholar
• Lee MG, Phimister A, Morin D, Buckpitt A, Plopper C. (2005). In situ naphthalene bioactivation and nasal airflow cause region-specific injury patterns in the nasal mucosa of rats exposed to naphthalene by inhalation. J Pharmacol Exp Ther 314:103–110.
   PubMed Web of Science ®Google Scholar
• Long PH, Herbert RA, Peckham JC, Grumbein SL, Shackelford CC, Abdo K. (2003). Morphology of nasal lesions in F344/N rats following chronic inhalation exposure to naphthalene vapors. Toxicol Pathol 31:655–664.
   PubMed Web of Science ®Google Scholar
• Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591–653.
   PubMed Web of Science ®Google Scholar
• Morris JB, Buckpitt AR. (2009). Upper respiratory tract uptake of naphthalene. Toxicol Sci 111:383–391.
   PubMed Web of Science ®Google Scholar
• Nagata K, Martin BM, Gillette JR, Sasame HA. (1990). Isozymes of cytochrome P-450 that metabolize naphthalene in liver and lung of untreated mice. Drug Metab Dispos 18:557–564.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program (NTP). (1992). Toxicology and Carcinogenesis Studies of Naphthalene (CAS No. 91-20-3) in B6C3F1 Mice (Inhalation Studies). Bethesda, MD: US Public Health Service, National Institutes of Health. NTP-TR-410; NIH publication no. 92-3141.
   Google Scholar
• NTP. (2000). Toxicology and Carcinogenesis Studies of Naphthalene (CASD No. 91-20-3) in F344/N Rats (Inhalation Studies). National Toxicology Program. Rockville, MD: US Department of Health and Human Services, National Institutes of Health. Technical report series no. 500.
   Google Scholar
• North DW, Abdo KM, Benson JM, Dahl AR, Morris JB, Renne R, Witschi H. (2008). A review of whole animal bioassays of the carcinogenic potential of naphthalene. Regul Toxicol Pharmacol 51(2 Suppl 1):6–14.
   Web of Science ®Google Scholar
• Oliver JR, Kushwah R, Wu J, Cutz E, Yeger H, Waddell TK, Hu J. (2009). Gender differences in pulmonary regenerative response to naphthalene-induced bronchiolar epithelial cell injury. Cell Prolif 2009 Oct;42(5):672-87.
   PubMed Web of Science ®Google Scholar
• Phimister A, Lee M, Morin D, Buckpitt AR, Plopper CG. (2004). Glutathione depletion is a major determinant of inhaled naphthalene respiratory toxicity and naphthalene metabolism in mice. Toxicol Sci 82:268–278.
   PubMed Web of Science ®Google Scholar
• Plopper CG, Suverkropp C, Morin D, Nishio S, Buckpitt A. (1992a). Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. J Pharmacol Exp Ther 261:353–363.
   PubMed Web of Science ®Google Scholar
• Plopper CG, Macklin J, Nishio SJ, Hyde DM, Buckpitt AR. (1992b). Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, and rats after parenteral administration of naphthalene. Lab Invest 67:553–565.
   PubMed Web of Science ®Google Scholar
• Raunio H, Hakkola J, Hukkanen J, Lassila A, Paivarinta L, Pelkonen O, Anttila S, Piipari R, Boobis A, Edwards RJ. (1999). Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. Exp Toxicol Pathol 51:412–417.
   PubMed Web of Science ®Google Scholar
• Saeed M, Higginbotham S, Rogan E, Cavalieri E. (2007). Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene. Chem Biol Interact 165:175–188.
   PubMed Web of Science ®Google Scholar
• Saeed M, Higginbotham S, Gaikwad N, Chakravarti D, Rogan E, Cavalieri E. (2009). Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation. Free Radic Biol Med 47:1075–1081.
   PubMed Web of Science ®Google Scholar
• Schreiner CA. (2003). Genetic toxicity of naphthalene: A review. J Toxicol Environ Health B Crit Rev 6:161–183.
   PubMed Web of Science ®Google Scholar
• Shultz MA, Choudary PV, Buckpitt AR. (1999). Role of murine cytochrome P-450 2F2 in metabolic activation of naphthalene and metabolism of other xenobiotics. J Pharmacol Exp Ther 290:281–288.
   PubMed Web of Science ®Google Scholar
• Simmonds AC, Ghanayem BI, Sharma A, Reilly CA, Millen B, Yost GS, Forkert, PG. (2004). Bioactivation of 1,1-dichloroethylene by CYP2E1 and CYP2F2 in murine lung. J Pharmacol Exp Ther. 310:855–864.
   PubMed Web of Science ®Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, Mangelsdorf I, Meek E, Rice JM, Younes M. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34:146–152.
   PubMed Web of Science ®Google Scholar
• Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X. (2000). Human cytochrome P450 CYP2A13: Predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074–5079.
   PubMed Web of Science ®Google Scholar
• Thornton-Manning JR, Dahl AR. (1997). Metabolic capacity of nasal tissue interspecies comparisons of xenobiotic-metabolizing enzymes. Mutat Res 380:43–59.
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency (US EPA). (2001). Toxicological Review of Chloroform (CAS No. 67-66-3), In Support of Summary Information on the Integrated Risk Information System (IRIS). October. Available at: http://www.epa.gov/ncea/iris/toxreviews/0025tr.pdf.
   Google Scholar
• US EPA. (2004). Toxicological review of naphthalene (CAS No. 91-20-3) In Support of Summary Information on the Integrated Risk Information System (IRIS). NCEA-S-1707, June 2004, External review draft. Washington, DC: Office of Research and Development.
   Google Scholar
• Van Winkle L, Isaac J, Plopper C. (1997). Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am J Pathol 151:443–459.
   PubMed Web of Science ®Google Scholar
• Van Winkle LS, Buckpitt AR, Nishio SJ, Isaac JM, Plopper CG. (1995). Cellular responses in naphthalene-induced Clara cell injury and bronchiolar epithelial repair in mice. Am J Physiol 269(6 Pt 1):L800–L818.
   Google Scholar
• Van Winkle LS, Evans MJ, Brown CD, Willits NH, Pinkerton KE, Plopper CG. (2001). Prior exposure to aged and diluted sidestream cigarette smoke impairs bronchiolar injury and repair. Toxicol Sci 60:152–164.
   PubMed Web of Science ®Google Scholar
• Van Winkle LS, Brown CD, Shimizu JA, Gunderson AD, Evans MJ, Plopper CG. (2004). Impaired recovery from naphthalene-induced bronchiolar epithelial injury in mice exposed to aged and diluted sidestream cigarette smoke. Toxicol Lett 154:1–9.
   PubMed Web of Science ®Google Scholar
• Waidyanatha S, Rappaport SM. (2008). Hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone in Swiss Webster mice. Chem Biol Interact 172:105–114.
   PubMed Web of Science ®Google Scholar
• Waidyanatha S, Troester MA, Lindstrom AB, Rappaport SM. (2002). Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone after administration of naphthalene to F344 rats. Chem Biol Interact 141:189–210.
   PubMed Web of Science ®Google Scholar
• West JA, Pakehham G, Morin D, Fleschneer CA, Buckpitt AR, Plopper CG. (2001). Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats. Toxicol Appl Pharmacol 173:114–119.
   PubMed Web of Science ®Google Scholar
• Wilson AS, Davis CD, Williams DP, Buckpitt AR, Pirmohamed M, Park BK. (1996). Characterization of the toxic metabolite(s) of naphthalene. Toxicology 114:233–242.
   PubMed Web of Science ®Google Scholar
• Zheng J, Cho M, Jones AD, Hammock BD. (1997). Evidence of quinone metabolites of naphthalene covalently bound to sulfur nucleophiles of proteins of murine Clara cells after exposure to naphthalene. Chem Res Toxicol 10:1008–1014.
   Google Scholar